<abstract xmlns="http://www.w3.org/1999/xhtml"><p> The prospective study analyses prevalence of coronary heart disease, stroke, elevated serum levels of ALT and GGT and prevalence of cancer diseases in patients with newly diagnosed type 2 diabetes mellitus, and usage of this epidemiological data in everyday clinical practice. Outpatients with newly diagnosed type 2 diabetes mellitus were monitoring during the period of August 2007 - August 2011. The patients with previously treated type 2 diabetes mellitus were eliminated from the monitoring. The population consists of 117 males and 83 females aged 30 to 92 years sent by GPs and various specialists.</p><p>The relatively low prevalence of known coronary artery disease was recorded in men (34%) and in women (19%). Prevalence of stroke history was confirmed in 12% of men and 7% of women. The elevated serum ALT levels > 0.55 μkat/l was recorded in 45% of men and 45% of women and elevated serum GGT levels > 0.45 μkat/l was recorded in 81% of men and 68% of women. Prevalence of cancer diseases was recorded 5% in women and 5.26% of men. In the studied group of patients there was recorded the occurrence of colon cancer in men over 64 years old and the occurrence of breast cancer, endometrial cancer and colon cancer in women over 62 years old.</p></abstract>

The prospective study analyses prevalence of coronary heart disease, stroke, elevated serum levels of ALT and GGT and prevalence of cancer diseases in patients with newly diagnosed type 2 diabetes mellitus, and usage of this epidemiological data in everyday clinical practice. Outpatients with newly diagnosed type 2 diabetes mellitus were monitoring during the period of August 2007 - August 2011. The patients with previously treated type 2 diabetes mellitus were eliminated from the monitoring. The population consists of 117 males and 83 females aged 30 to 92 years sent by GPs and various specialists.The relatively low prevalence of known coronary artery disease was recorded in men (34%) and in women (19%). Prevalence of stroke history was confirmed in 12% of men and 7% of women. The elevated serum ALT levels > 0.55 μkat/l was recorded in 45% of men and 45% of women and elevated serum GGT levels > 0.45 μkat/l was recorded in 81% of men and 68% of women. Prevalence of cancer diseases was recorded 5% in women and 5.26% of men. In the studied group of patients there was recorded the occurrence of colon cancer in men over 64 years old and the occurrence of breast cancer, endometrial cancer and colon cancer in women over 62 years old.

The Prevalence of Coronary Heart Disease, Stroke and Selected Co-Morbidities in Patients with Newly Diagnosed Type 2 Diabetes Population - Based on Cohort Study of Outpatients

Clinic of Internal Medicine, Faculty Hospital F.D.Roosvelt in Banska Bystrica, Outpatient Department of Diabetes phone: +421908532428

Clinic of Internal Medicine I, Jessenius Faculty of Medicine, Comenius University and University Hospital in Martin, Slovakia

Acta Medica Martiniana

The prospective study analyses prevalence of coronary heart disease, stroke, elevated serum levels of ALT and GGT and prevalence of cancer diseases in patients...

The Prevalence of Coronary Heart Disease, Stroke and Selected Co-Morbidities in Patients with Newly Diagnosed Type 2 Diabetes Population - Based on Cohort Study of Outpatients

Published Online: May 14, 2013

Page range: 33 - 43

DOI: https://doi.org/10.2478/acm-2013-0010

Keywords
prevalence, newly diagnosed type 2 diabetes mellitus, stroke, coronary heart disease, cancer, steatosis

This content is open access.

The Prevalence of Coronary Heart Disease, Stroke and Selected Co-Morbidities in Patients with Newly Diagnosed Type 2 Diabetes Population - Based on Cohort Study of Outpatients

Published Online: May 14, 2013

Page range: 33 - 43

DOI: https://doi.org/10.2478/acm-2013-0010

Keywordsprevalence, newly diagnosed type 2 diabetes mellitus, stroke, coronary heart disease, cancer, steatosis

This content is open access.

Keywords
prevalence, newly diagnosed type 2 diabetes mellitus, stroke, coronary heart disease, cancer, steatosis